Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jaroslav, Ludvik"'
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 250 (2022)
Since Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) was introduced as a new thyroid tumour entity, many studies, and meta-analyses on diagnosing NIFTP have been published. NIFTP-revised histopathological criteri
Externí odkaz:
https://doaj.org/article/5c3cf7b5cd94403fa2131a69dd6e6c9d
Autor:
David Kalfert, Marie Ludvikova, Martin Pesta, Jaroslav Ludvik, Lucie Dostalova, Ivana Kholová
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 563 (2020)
MiR-34a belongs to the class of small non-coding regulatory RNAs and functions as a tumor suppressor. Under physiological conditions, miR-34a has an inhibitory effect on all processes related to cell proliferation by targeting many proto-oncogenes an
Externí odkaz:
https://doaj.org/article/a1a8511321fd49da9c8428512c77b3a6
Autor:
Martin Sedlmair, Jiri Ferda, Martin Svatoň, Jan Baxa, Thomas Flohr, Miloš Pešek, Jaroslav Ludvik, Bernhard Schmidt, Petr Hosek
Publikováno v:
Anticancer Research. 40:3459-3468
AIM To compare iodine-related and fluorine-18 fluorodeoxyglucose (18F-FDG) parameters during staging of lung cancer as well as during early follow-up, while investigating potential use and possible substitutability in the assessment of therapeutic re
Publikováno v:
Diagnostics (Basel, Switzerland). 12(2)
Since Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) was introduced as a new thyroid tumour entity, many studies, and meta-analyses on diagnosing NIFTP have been published. NIFTP-revised histopathological criteri
Autor:
Marie Ludvíková, Ivana Kholová, David Kalfert, Lucie Dostalova, Jaroslav Ludvik, Martin Pesta
Publikováno v:
Diagnostics
Diagnostics, Vol 10, Iss 563, p 563 (2020)
Diagnostics, Vol 10, Iss 563, p 563 (2020)
MiR-34a belongs to the class of small non-coding regulatory RNAs and functions as a tumor suppressor. Under physiological conditions, miR-34a has an inhibitory effect on all processes related to cell proliferation by targeting many proto-oncogenes an
Autor:
Vaclav Liska, Skalicky T, Radek Kucera, Jiri Ferda, Daniel Lysák, Jakub Fichtl, Inka Treskova, Jan Bruha, Vladislav Treska, Jaroslav Ludvik, Ondrej Topolcan
Publikováno v:
Anticancer Research. 38:5531-5537
BACKGROUND Portal vein embolization (PVE) and PVE with autologous mesenchymal stem cell application (PVE-MSC) increases future liver remnant volume (FLRV). The aim of this study was to compare both methods from the aspect of FLRV growth, progression
Autor:
Jiri Bejcek, Martin Sedlmair, Jaroslav Ludvik, Miloš Pešek, Thomas Flohr, Bernhard Schmidt, Tana Matouskova, Jan Baxa, Jiri Ferda
Publikováno v:
Anticancer Research. 38:4131-4137
Aim: The aim of the study was to assess possible correlation of fluorogeoxyglucose (FDG) uptake and iodine-related attenuation values derived from positron-emission tomography/computed tomography (PET/CT) using single-source dual-energy CT scan (DE-C
Autor:
Jan Baxa, David Suchý, Daniel Rajdl, Jitka Seidlerová, Jan Lhotský, Richard Rokyta, Jaroslav Ludvik, Milan Hromádka
Publikováno v:
International Journal of Cardiology. 249:448-453
Systemic scleroderma (SSc) is a rare connective tissue disease presenting with fibrosis affecting skin and internal organs. Cardiovascular magnetic resonance (CMR) with quantification of extracellular volume (ECV) and T1 mapping might help to detect
Autor:
Jan Baxa, Jiří Ferda, Petr Duras, Vladislav Třeška, Daniel Lysák, Jakub Fichtl, Táňa Matoušková, Jaroslav Ludvik, Brůha J
Publikováno v:
CardioVascular and Interventional Radiology. 40:690-696
This study aimed to evaluate the progress of future liver remnant volume (FLRV) in patients with liver metastases after portal vein embolization (PVE) with the application of hematopoietic stem cells (HSCs) and compare it with a patients control grou
Autor:
Ivana Kholová, Petr Celakovsky, David Kalfert, Jan Plzak, Marie Ludvíková, Martin Pesta, Jaroslav Ludvik, Ondrej Topolcan, Radek Kucera
Publikováno v:
Anticancer research. 39(9)
BACKGROUND/AIM The aim of this study was to analyze the pretreatment cytokeratin serum levels in head and neck squamous cell carcinoma (HNSCC) by three assays in relation to selected clinicopathological characteristics in an effort to find diagnostic